Sunflower Pharmaceutical Group Co., Ltd. (SZSE: 002737)
Health Care · Pharmaceuticals · CN
CN¥13.04
-4.26% today · -19.8% 1Y
Sunflower Pharmaceutical Group Co., Ltd. (SZSE: 002737) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.13B and employs 5,025 people.
Over the last twelve months the share price has lost 19.8%, trading between 11.04 and 16.42.
Tweenvest scores Sunflower Pharmaceutical Group Co., Ltd. across four factors: quality 76/100, value 58/100, growth 0/100, dividend 90/100. Its strongest factor is dividend.
002737 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.13B
- Revenue (TTM)
- $362.22M
- P/E
- —
- EPS
- -0.35
- Dividend yield
- 1.47%
- Beta (5Y)
- 0.26
- 52-week high
- CN¥16.42
- 52-week low
- CN¥11.04
- Avg volume (3M)
- —
- Shares outstanding
- 584.00M
- Employees
- 5,025
- Next earnings
- —
About Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co., Ltd. is a Chinese enterprise dedicated to the comprehensive process of traditional Chinese medicine (TCM), covering everything from research and development to production and market distribution within China. The company's product range also extends to include chemical, biological, and health-focused pharmaceuticals. These diverse medications address a broad spectrum of medical needs, providing solutions in areas such as pediatrics, gynecology, digestive system ailments, respiratory issues including the common cold, conditions related to rheumatism and bone health, and cardiovascular and cerebrovascular disorders. The company's goods are sold under its established brands, "Sunflower" and "Little Sunflower." With its headquarters located in Harbin, China, Sunflower Pharmaceutical Group was founded in 2005.
- ISIN
- CNE100001WT7
- Founded
- 2005
- Listed since
- Dec 30, 2014
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.